Non-steroidal anti-inflammatory drug use in the elderly

Alberto Pilotto, Daniele Sancarlo, Filomena Addante, Carlo Scarcelli, Marilisa Franceschi

Research output: Contribution to journalArticle

Abstract

The efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of inflammation and pain of various origins is well established. Prescribing these drugs, however, remains a challenge because a great variety of gastrointestinal and cardiovascular safety issues need to be considered, particularly in older patients. Recent recommendations suggest that the prescription of non-selective NSAIDs and/or selective cyclo-oxygenase-2 inhibitors (coxibs) may be appropriate in patients with low gastrointestinal risk (no prior gastrointestinal events, no concomitant treatments with other damaging drugs). Gastroprotection is appropriate in patients with gastrointestinal risk factors and in older patients. In patients at high risk for gastrointestinal and cardiovascular events, however, NSAID or coxib prescriptions are contraindicated. Multidimensional impairment is a crucial point in evaluating the clinical outcome of older patients; thus, a comprehensive geriatric assessment is useful in predicting adverse outcomes, including morbidity and mortality.

Original languageEnglish
Pages (from-to)167-172
Number of pages6
JournalSurgical Oncology
Volume19
Issue number3
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Anti-Inflammatory Agents
Pharmaceutical Preparations
Prescriptions
Geriatric Assessment
Drug Prescriptions
Cyclooxygenase Inhibitors
Inflammation
Morbidity
Safety
Pain
Mortality
Therapeutics

Keywords

  • Elderly
  • NSAID
  • Pain

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Non-steroidal anti-inflammatory drug use in the elderly. / Pilotto, Alberto; Sancarlo, Daniele; Addante, Filomena; Scarcelli, Carlo; Franceschi, Marilisa.

In: Surgical Oncology, Vol. 19, No. 3, 09.2010, p. 167-172.

Research output: Contribution to journalArticle

Pilotto, A, Sancarlo, D, Addante, F, Scarcelli, C & Franceschi, M 2010, 'Non-steroidal anti-inflammatory drug use in the elderly', Surgical Oncology, vol. 19, no. 3, pp. 167-172. https://doi.org/10.1016/j.suronc.2009.11.014
Pilotto, Alberto ; Sancarlo, Daniele ; Addante, Filomena ; Scarcelli, Carlo ; Franceschi, Marilisa. / Non-steroidal anti-inflammatory drug use in the elderly. In: Surgical Oncology. 2010 ; Vol. 19, No. 3. pp. 167-172.
@article{e1d0c38d91fd4512984769ebb6005f46,
title = "Non-steroidal anti-inflammatory drug use in the elderly",
abstract = "The efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of inflammation and pain of various origins is well established. Prescribing these drugs, however, remains a challenge because a great variety of gastrointestinal and cardiovascular safety issues need to be considered, particularly in older patients. Recent recommendations suggest that the prescription of non-selective NSAIDs and/or selective cyclo-oxygenase-2 inhibitors (coxibs) may be appropriate in patients with low gastrointestinal risk (no prior gastrointestinal events, no concomitant treatments with other damaging drugs). Gastroprotection is appropriate in patients with gastrointestinal risk factors and in older patients. In patients at high risk for gastrointestinal and cardiovascular events, however, NSAID or coxib prescriptions are contraindicated. Multidimensional impairment is a crucial point in evaluating the clinical outcome of older patients; thus, a comprehensive geriatric assessment is useful in predicting adverse outcomes, including morbidity and mortality.",
keywords = "Elderly, NSAID, Pain",
author = "Alberto Pilotto and Daniele Sancarlo and Filomena Addante and Carlo Scarcelli and Marilisa Franceschi",
year = "2010",
month = "9",
doi = "10.1016/j.suronc.2009.11.014",
language = "English",
volume = "19",
pages = "167--172",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Non-steroidal anti-inflammatory drug use in the elderly

AU - Pilotto, Alberto

AU - Sancarlo, Daniele

AU - Addante, Filomena

AU - Scarcelli, Carlo

AU - Franceschi, Marilisa

PY - 2010/9

Y1 - 2010/9

N2 - The efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of inflammation and pain of various origins is well established. Prescribing these drugs, however, remains a challenge because a great variety of gastrointestinal and cardiovascular safety issues need to be considered, particularly in older patients. Recent recommendations suggest that the prescription of non-selective NSAIDs and/or selective cyclo-oxygenase-2 inhibitors (coxibs) may be appropriate in patients with low gastrointestinal risk (no prior gastrointestinal events, no concomitant treatments with other damaging drugs). Gastroprotection is appropriate in patients with gastrointestinal risk factors and in older patients. In patients at high risk for gastrointestinal and cardiovascular events, however, NSAID or coxib prescriptions are contraindicated. Multidimensional impairment is a crucial point in evaluating the clinical outcome of older patients; thus, a comprehensive geriatric assessment is useful in predicting adverse outcomes, including morbidity and mortality.

AB - The efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of inflammation and pain of various origins is well established. Prescribing these drugs, however, remains a challenge because a great variety of gastrointestinal and cardiovascular safety issues need to be considered, particularly in older patients. Recent recommendations suggest that the prescription of non-selective NSAIDs and/or selective cyclo-oxygenase-2 inhibitors (coxibs) may be appropriate in patients with low gastrointestinal risk (no prior gastrointestinal events, no concomitant treatments with other damaging drugs). Gastroprotection is appropriate in patients with gastrointestinal risk factors and in older patients. In patients at high risk for gastrointestinal and cardiovascular events, however, NSAID or coxib prescriptions are contraindicated. Multidimensional impairment is a crucial point in evaluating the clinical outcome of older patients; thus, a comprehensive geriatric assessment is useful in predicting adverse outcomes, including morbidity and mortality.

KW - Elderly

KW - NSAID

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=77955920715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955920715&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2009.11.014

DO - 10.1016/j.suronc.2009.11.014

M3 - Article

C2 - 20022240

AN - SCOPUS:77955920715

VL - 19

SP - 167

EP - 172

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 3

ER -